This study integrated paired airway and blood multiomics to characterize immune adaptation across the airway-blood axis during the first week of life in neonates. Researchers collected deep pharyngeal aspirates (DPA) and matched whole blood from 19 infants spanning extreme preterm (<28 weeks) to term gestation. Samples were obtained at two postnatal time windows: days 1–3 and days 4–10. Ethical approvals were obtained from the appropriate institutional review boards, and participant consent was reported.
Paired single-cell RNA sequencing (scRNA-seq) and mass spectrometry–based plasma proteomics were performed on the matched DPA and blood samples. The integrated multiomic approach enabled simultaneous assessment of cell composition, cell-state–specific gene expression, and circulating protein signatures across mucosal (airway) and systemic (blood) compartments. The resulting dataset was assembled into a multiomic atlas describing compartmental and temporal patterns in the first postnatal week.
Analysis revealed gestational age–dependent alterations in cell composition in both compartments. In blood, immature hematopoietic and myeloid populations were expanded in more premature infants. In DPA samples, distinct myeloid and epithelial programs were observed that varied with gestational age. These shifts indicate that the degree of prematurity influences both systemic and mucosal immune cell landscapes during early postnatal life.
The study reported compartment-specific patterns of inflammatory and innate immune gene expression that evolved over the first week after birth. While both airway and blood compartments showed coordinated adaptation, each compartment displayed unique gene-expression signatures and temporal dynamics. The data indicate that systemic and mucosal immune remodeling after birth is both coordinated across compartments and tailored to local tissue contexts.
An unexpected finding was the detection of a circulating respiratory epithelial–like cell population in neonatal blood. The abundance of these cells correlated with prematurity and with measures of lung disease in the cohort. The authors validated this population by flow cytometry and by confirming its presence in independent datasets. The study presents these circulating epithelial-like cells as a candidate blood-accessible signal of perturbation at the airway–blood interface in neonates.
Matched plasma proteomics identified two principal axes in the circulating proteome: a gestational age axis and a disease-associated axis. Specific lung-restricted proteins were used to derive composite measures that relate to organ injury and to clinical trajectories. The proteomic data therefore complemented the single-cell transcriptomic findings and provided system-level signatures linked to both maturity and disease state.
The investigators derived an Organ-to-System Score from lung-restricted plasma proteins. This score tracked lung injury severity and, notably, distinguished trajectories toward chronic lung disease as early as 72 hours after birth in this dataset. The Organ-to-System Score is presented as a potential early biomarker for neonatal lung injury and for stratifying risk of chronic lung disease, subject to validation in larger cohorts.
From multiomic integration and signaling-prioritization analyses, the study highlighted ciliated–myeloid signaling via the LAMA5-ITGB1 ligand–receptor interaction as a candidate axis that may underlie neonatal lung disease. This signaling pair was prioritized as a potentially relevant intercellular communication route between airway epithelial (ciliated) cells and myeloid cells in the neonatal lung environment.
The paired airway–blood multiomic atlas provides a systems-level framework for biomarker discovery and mechanistic studies. Candidate blood-accessible signals — including circulating respiratory epithelial–like cells and lung-restricted proteomic signatures summarized by the Organ-to-System Score — could enable earlier detection of lung injury and identification of infants at risk for chronic lung disease. The authors suggest these findings as a platform to guide targeted validation and larger cohort studies to assess clinical utility.
The manuscript reports that institutional ethical approvals and participant consent were obtained. All data produced in the study are available upon reasonable request to the authors. Funding sources for the work include several organizations named in the source. The authors declared no competing interests.
Note on limitations and further validation: the source presents the multiomic findings and reports validation of the circulating epithelial-like cells by flow cytometry and independent datasets. Details on cohort-level clinical outcome measures, statistical effect sizes, and specific protein or gene lists beyond the highlighted findings are reported in the original manuscript; any additional numerical details or subgroup analyses not summarized here were not reported in the source text provided.